Stay updated on AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial

Sign up to get notified when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology during the website transition appears, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:16:22.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:10:17.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual content and indicating restricted access to the study information. This prevents users from viewing trial details like eligibility, status, and results on this page.
    Difference
    0.5%
    Check dated 2026-09-29T19:34:51.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record. This suggests access to the study details is blocked.
    Difference
    19%
    Check dated 2026-09-22T21:46:19.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    A revision tag on the page was updated to v3.7.0. The previous v3.6.6 tag was removed.
    Difference
    0.0%
    Check dated 2026-09-15T20:55:00.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a small update to the page template or backend tracking. There is no change to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T18:25:32.000Z thumbnail image

Stay in the know with updates to AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.